Alma, a Sisram Medical Company, Announces Strategic Collaboration with Celebrity Skin Expert Nurse Jamie to Expand Global Consumer Presence
With more than two decades of experience as a registered nurse specializing in aesthetics, Nurse Jamie has become a trusted authority in beauty and skin health. Her results-driven approach and innovative treatments have earned her a loyal celebrity clientele and recognition in leading beauty and lifestyle media. She also served as executive producer and co-host of the hit Netflix series Skin Decision: Before and After, which brought her expertise in transformative skin care to an international audience.
Through this collaboration, Sherrill will serve as representative for Alma's flagship platforms, including
"Alma is proud to collaborate with Nurse Jamie, a respected leader in aesthetics and a trusted name for millions of consumers," said
"For me, this partnership is built on trust and transformation," said
About
Sisram serves customers in over 110 countries and regions, delivering award-winning products that set new standards in safety, efficacy, and personalized aesthetic care for millions of patients worldwide.
The Company is majority-owned by Fosun Pharma, one of
http://www.sisram-medical.com
About Alma
Alma is a global leader in medical aesthetic solutions, with over 25 years of innovation. The company empowers practitioners to deliver safe, effective, and transformative treatments to their patients through state-of-the-art, clinically proven solutions spanning energy-based device lasers, diagnostics, injectables, and advanced skincare. Alma's multiple award-winning products have set new benchmarks in the medical aesthetic industry, both in terms of clinical excellence and groundbreaking innovation.
For more information about Alma and its products, visit almalasers.com.
View original content:https://www.prnewswire.com/news-releases/alma-a-sisram-medical-company-announces-strategic-collaboration-with-celebrity-skin-expert-nurse-jamie-to-expand-global-consumer-presence-302546634.html
SOURCE